Korell, F., Schubert, M., Sauer, T., Schmitt, A., Derigs, P., Weber, T., . . . Schmitt, M. (2021). Infection complications after lymphodepletion and dosing of chimeric antigen receptor T (CAR-T) cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia or B cell non-Hodgkin lymphoma. Cancers, 13(7), . https://doi.org/10.3390/cancers13071684
Chicago-Zitierstil (17. Ausg.)Korell, Felix, et al. "Infection Complications After Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma." Cancers 13, no. 7 (2021). https://doi.org/10.3390/cancers13071684.
MLA-Zitierstil (9. Ausg.)Korell, Felix, et al. "Infection Complications After Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma." Cancers, vol. 13, no. 7, 2021, https://doi.org/10.3390/cancers13071684.